Strengths
- CB Insights lists Augury as a unicorn at $1B.
- Public company materials show an active product platform in Industrials / Industrial AI, machine health and predictive maintenance.
- Public leadership/team signals indicate an operating company.
Augury Startup Diligence Report
Proceed only to confirmatory diligence. The case for Augury depends on proving revenue quality, durable customer economics, defensible product adoption, legal/regulatory posture, team retention and financing terms beyond public-list valuation evidence.
Augury Startup Diligence Report
Augury appears eligible as an active private unicorn based on the CB Insights unicorn list and current public web presence. Public evidence supports product/category activity and selected traction or financing signals, but core diligence remains unresolved because financial statements, cap table, customer concentration, contracts, security/legal artifacts and detailed operating metrics are private.
The public $1B unicorn signal and funding milestones do not disclose ARR, gross margin, burn, cash runway or pricing quality.
Diligence request: Request audited financials, ARR by cohort, gross margin, CAC/payback, cash and financing documents.
Company-published six-month payback claims are not enough to verify realized savings, renewal health or reference quality.
Diligence request: Request customer cohorts, avoided-loss calculations, renewal data and independent reference calls.
Machine-health products depend on sensors, plant integrations, uptime, field support and customer change management.
Diligence request: Request deployment cycle-time, hardware BOM, supplier concentration, support SLAs and gross-margin bridge.
Public traction signals do not reveal top-customer revenue, churn, NRR, renewals or contract terms.
Diligence request: Request top-customer schedule, contract summaries, churn/NRR cohorts and references.
Public category positioning implies competition from incumbents and specialist startups; win/loss evidence is not public.
Diligence request: Request competitor benchmarks, win/loss, pricing pressure and buyer references.
Public materials imply important third-party, supplier or platform dependencies that are not disclosed in contract-level detail.
Diligence request: Request supplier contracts, concentration schedule, service-level history and exit plans.
Public leadership roster does not disclose retention, incentives, turnover or succession risk.
Diligence request: Request org chart, retention metrics, employment agreements and compensation plans.
Public web review is not a full docket, contract, insurance, privacy, employment or IP search.
Diligence request: Have counsel complete litigation, regulatory, IP, privacy and material-contract review.
Augury's public valuation and financing signals are useful screening anchors, but financial statements, KPI quality, cap table and current valuation support are private.
partially verified confidence: medium
Public sources do not disclose audited financial statements, full KPI packs, AR aging, backlog or cash-flow quality for Augury.
| metric | public signal | diligence request | status |
|---|---|---|---|
| Revenue / ARR | No audited public revenue or ARR found. | Audited financials, revenue bridge, billings, backlog and revenue-recognition policy. | not_publicly_verifiable |
| Gross margin / unit economics | No complete public margin data found. | Product/customer gross margin, support/infrastructure cost and contribution margin. | not_publicly_verifiable |
| Cash / debt / runway | Financing or scale signals exist, but cash/debt not disclosed. | Cash, debt, burn, runway, covenants and off-balance-sheet obligations. | not_publicly_verifiable |
partially verified confidence: medium
A public valuation/list signal exists ($1B), but projections, budget-to-actuals and valuation bridge require private records.
partially verified confidence: medium
Public investor/list data does not reveal share classes, preferences, debt, warrants, option pool or control terms.
| stakeholder | public position | diligence caveat | source |
|---|---|---|---|
| Known public investors | Lerer Hippeau, Munich Re Ventures, Eclipse Ventures | Ownership percentages, preferences and board rights are private. | CB Insights |
| Common/preferred shareholders | not_publicly_verifiable | Request cap table, option pool, SAFEs/notes and warrants. | Company data room |
| Debt / credit / off-balance-sheet obligations | not_publicly_verifiable | Request debt instruments, leases, guarantees and contingent liabilities. | Company data room |
partially verified confidence: medium
Public financing/valuation events are useful screening anchors but incomplete for transaction diligence.
| date | event | amount or valuation | source | verification status |
|---|---|---|---|---|
| 2021-10-26 | CB Insights unicorn-list valuation | $1B | CB Insights Global Unicorn Club | verified for public-list entry |
| current | Latest priced round and current valuation bridge | not_publicly_verifiable | Company data-room request | not_publicly_verifiable |
| current | Cash, debt, preferences and option pool | not_publicly_verifiable | Company data-room request | not_publicly_verifiable |
Augury publicly markets an active product platform, but adoption depth, roadmap economics and product-level margin require private evidence.
partially verified confidence: medium
Public materials describe Augury's product platform and target use cases, but roadmap, product margin, adoption and reliability require private evidence.
| product | audience | key features | public evidence | verification status |
|---|---|---|---|---|
| Industrial AI Workforce | Manufacturing teams | Combines machine and operational data, monitoring, intelligence and AI agents | SRC-002 | partially_verified |
| Machine Health | Reliability and maintenance teams | Prescriptive AI machine diagnostics to predict and prevent industrial machine failure | SRC-004 | verified |
| Process Health | Process and operations teams | Prescriptive AI process optimization, previously known as Seebo | SRC-002 | partially_verified |
| Auguscope | Plant maintenance users | Smartphone-connected machine health product launched in early company history | SRC-002 | partially_verified |
| item | public signal | diligence request | status |
|---|---|---|---|
| Published list pricing / fee schedule | Public materials reviewed did not provide complete realized pricing waterfall for diligence purposes. | List prices, realized ACV/fees, discounts, take rates and renewal uplift. | partially_verified |
| Enterprise/customer contracts | Contracts not public. | Top contracts, renewal terms, SLAs, termination rights and most-favored-nation clauses. | not_publicly_verifiable |
| Gross-margin drivers | Cost structure not public. | Cost of service, support, infrastructure, claims/hardware/custody costs as applicable. | not_publicly_verifiable |
Public customer/partner signals exist, but revenue concentration, churn, contracts and renewal health are not public.
partially verified confidence: medium
Public customer/usage signals exist, but top-customer list, contract value and purchase timing are private.
| customer or signal | source | use case | public evidence | verification status |
|---|---|---|---|---|
| Manufacturers in 10+ verticals | Company about page | Industrial AI / predictive maintenance | Public company statement; revenue concentration not disclosed | partially_verified |
| Nefco / Bausch Health public logo signals | Company about imagery | Logo/reference signal | Logo presence does not verify contract size or renewal status | inconclusive |
| Top 15 customers and ARR by customer | Not public | Revenue concentration | Request contract and cohort schedules | not_publicly_verifiable |
partially verified confidence: medium
Public strategic relationship signals exist, but revenue contribution, exclusivity and termination rights are private.
| relationship | nature | public evidence | gap or risk |
|---|---|---|---|
| Baker Hughes | Company investor logo / strategic signal | Industrial ecosystem and investment signal | Request commercial scope and related-party terms |
| Munich Re Ventures | CB Insights/company investor signal | Investor / insurance-technology signal | Request financing terms and board rights |
| Eclipse Ventures / Lerer Hippeau | CB Insights/company investor signal | Venture investors | Request cap table and preferences |
| Sensors and edge hardware | Machine-health data capture | Not fully disclosed | Request BOM, supplier concentration and warranty terms |
| Cloud/AI infrastructure | Data ingestion, model training and applications | Not disclosed | Request cloud spend, security architecture and SOC reports |
| Customer plant systems | Integration dependency | Public product implies OT/IT integration | Request integration backlog, data rights and deployment SLAs |
partially verified confidence: medium
Revenue by customer and concentration above 5% are not publicly verifiable.
not publicly verifiable confidence: low
Severed customer, partner or supplier relationships require management disclosure and contract review.
not publicly verifiable confidence: low
Top suppliers and purchase concentration are not publicly disclosed.
The public market position is competitive and requires win/loss, buyer references and pricing benchmarks.
partially verified confidence: medium
Public positioning places Augury in a competitive category; win/loss, pricing pressure and market share require buyer diligence.
| competitor | segment | funding or scale signal | product overlap | differentiator |
|---|---|---|---|---|
| Siemens | Industrial automation / digital industries | Large installed base and OT channels | Predictive maintenance and industrial analytics overlap | Distribution and enterprise relationships |
| GE Vernova / GE Digital | Industrial software and asset performance | Deep industrial asset pedigree | Asset performance management overlap | Domain breadth |
| PTC | Industrial IoT / ThingWorx | IoT platform and enterprise customers | Industrial analytics overlap | Platform ecosystem |
| Uptake | Industrial AI / asset performance | Predictive maintenance positioning | Analytics overlap | Data science and enterprise references |
| C3 AI | Enterprise AI | AI application platform and industrial deployments | AI analytics overlap | Platform breadth |
| axis | target position | competitor position | evidence or gap |
|---|---|---|---|
| Scale / liquidity / installed base | Public scale signal exists but quality is unverified. | Incumbents may have broader distribution or balance sheets. | Request win/loss and customer reference evidence. |
| Product breadth | Company markets multiple product modules. | Competitors also market broad suites or platform ecosystems. | Request product usage by module and attach rates. |
| Trust / compliance / security | Public trust or regulatory signals exist, but controls require diligence. | Public-company or regulated incumbents may offer stronger assurance. | Request SOC/security/legal/compliance packages. |
Qualitative map; not a market-share estimate.
Public GTM motions are visible, but CAC, payback, channel mix, quota and marketing budget sufficiency remain private.
partially verified confidence: medium
Public channels and positioning are visible, but sales productivity, CAC/payback and channel economics are private.
| channel | region or segment | public evidence | gap |
|---|---|---|---|
| Enterprise direct sales | Manufacturers and plant networks | Product/customer pages | Pipeline, quota and sales-cycle data are private |
| Strategic investors/partners | Industrial ecosystem | Investor logos and industry page signals | Commercial contribution unknown |
| Thought leadership and webinars | Reliability/maintenance teams | Website webinars and resources | Attribution and CAC unknown |
not publicly verifiable confidence: low
Major-customer trends cannot be underwritten from public logos or usage claims alone.
not publicly verifiable confidence: low
Principal avenues for new business are inferable from public channels, not quantitatively verified.
partially verified confidence: medium
Sales compensation, quota, ramp, sales cycle and productivity are private.
| metric | public signal | diligence request | status |
|---|---|---|---|
| Pipeline by source | Not public. | Pipeline generation, conversion and bookings by source/channel. | not_publicly_verifiable |
| CAC / payback | Not public. | CAC by channel, payback, LTV/CAC and marketing attribution. | not_publicly_verifiable |
| Quota / sales cycle | Not public. | Quota attainment, ramp, sales cycle, churn and win/loss data. | not_publicly_verifiable |
not publicly verifiable confidence: low
Budget adequacy for marketing/sales implementation is not public.
R&D/product signals are active publicly, while detailed roadmap, technical debt, incident history and development costs remain private.
partially verified confidence: medium
Public product/technology materials identify R&D themes, but team depth, technical debt and budget require private evidence.
| name or role | public role | background signal | source |
|---|---|---|---|
| Gal Shaul | Co-founder | Company timeline says Gal Shaul and Saar Yoskovitz launched the company | SRC-002 |
| Saar Yoskovitz | Co-founder | Company timeline says Gal Shaul and Saar Yoskovitz launched the company | SRC-002 |
| Industrial AI / reliability experts | R&D and domain specialists | Company product claim says AI is powered by reliability experts | SRC-004 |
partially verified confidence: medium
Pipeline initiatives are publicly visible at a high level; committed release dates, costs and risk burn-down are private.
| project | status | expected date or period | verification status |
|---|---|---|---|
| Industrial AI Workforce | Public website solution category | Current website category | partially_verified |
| Machine Health expansion | Prescriptive AI diagnostics across asset classes | Current product and use-case pages | partially_verified |
| Process Health / Seebo integration | AI-driven view into machines, processes and operations after Seebo acquisition | 2022 onward | partially_verified |
Leadership signals are public, but org depth, compensation, option plan, hiring and turnover require HR diligence.
partially verified confidence: medium
Public leadership signals exist, but the full organization chart requires HRIS and management confirmation.
Use private HRIS/org chart to replace this public approximation.
partially verified confidence: medium
Headcount by function/location and hiring plan are not fully public.
| period | public signal | source or request | verification status |
|---|---|---|---|
| current | Employee count by function/location | Not public in reviewed sources | not_publicly_verifiable |
| 2025 | Series F scaling signal | Company says it raised $75M to accelerate leadership in industrial AI solutions | partially_verified |
partially verified confidence: medium
Public leadership roster provides diligence starting points, not employment agreements or retention proof.
| name | role | public background or tenure | source |
|---|---|---|---|
| Gal Shaul | Co-founder | Named in company founding timeline | SRC-002 |
| Saar Yoskovitz | Co-founder | Named in company founding timeline | SRC-002 |
| Leadership team | Public leadership page | Management roster exists publicly but private org depth is not disclosed | SRC-006 |
not publicly verifiable confidence: low
Compensation arrangements and executive employment agreements are private.
not publicly verifiable confidence: low
Incentive stock plans, option pool and equity grants are private.
not publicly verifiable confidence: low
Employee-relations issues require HR/legal disclosure beyond public web review.
not publicly verifiable confidence: low
Turnover, regretted attrition and retention risks require HRIS data.
Public legal/regulatory/IP signals require counsel, contract, insurance and regulatory diligence before reliance.
partially verified confidence: medium
No complete public litigation docket search was performed; counsel must verify pending matters against the company.
| case | court or agency | filed date | status | source |
|---|---|---|---|---|
| Pending lawsuits against company | not_publicly_verifiable | not_publicly_verifiable | No complete docket search available from public web review. | Counsel docket search request |
| Regulatory/customer disputes | not_publicly_verifiable | not_publicly_verifiable | Requires jurisdiction-by-jurisdiction litigation, arbitration and complaint review. | Counsel/regulatory data-room request |
partially verified confidence: medium
Company-initiated litigation and enforcement actions require counsel review.
| defendant | court or agency | filed date | status | source |
|---|---|---|---|---|
| Pending company-initiated matters | not_publicly_verifiable | not_publicly_verifiable | No complete plaintiff-side docket search available from public web review. | Counsel docket search request |
| IP/licensing/contract enforcement | not_publicly_verifiable | not_publicly_verifiable | Requires trademark/patent docket and contract dispute review. | Counsel data-room request |
not publicly verifiable confidence: low
Environmental, safety and employment liabilities are not publicly verifiable from reviewed sources.
partially verified confidence: medium
Public brand/product/IP signals exist, but ownership, encumbrances and licenses require records.
| asset or matter | jurisdiction or counterparty | status | source |
|---|---|---|---|
| Augury brand and domains | Brand / websites | Publicly visible; trademark ownership not searched | SRC-002 |
| Machine Health diagnostics | AI/predictive maintenance software and models | Product capability public; ownership/patent protection not verified | SRC-004 |
| Process Health / Seebo assets | AI process optimization technology | Acquisition integration publicly described; IP chain-of-title requires records | SRC-002 |
| Company founded | 2011 | Company timeline says Gal Shaul and Saar Yoskovitz launched Augury in Israel | SRC-002 |
| Series E / unicorn event | 2021 | Company says it raised $180M in Series E to become an industrial AI unicorn | SRC-002 |
| Seebo acquisition | 2022 | Company timeline says Augury acquired Seebo to launch Production Health | SRC-002 |
| Pending litigation/regulatory actions | current | No public litigation/regulatory actions found in reviewed sources | SRC-002 |
not publicly verifiable confidence: low
Insurance coverage and material exposures are private.
not publicly verifiable confidence: low
Material contracts, change-of-control terms and off-balance-sheet commitments are private.
partially verified confidence: medium
Public legal/regulatory/restructuring signals require specialist counsel and jurisdiction-specific verification.
| ID | Claim | Status | Sources |
|---|---|---|---|
| EC-001 | Augury appears on CB Insights' Global Unicorn Club with valuation $1B. | verified high | SRC-001 |
| EC-002 | Augury is active on public company/product pages. | verified medium | SRC-002 |
| EC-003 | Augury has public product positioning in Industrials / Industrial AI, machine health and predictive maintenance. | partially verified medium | SRC-002 |
| EC-004 | Augury has public financing or scale signals beyond the unicorn list. | partially verified medium | SRC-003SRC-001 |
| EC-005 | Augury has public customer, usage or partner traction signals. | partially verified medium | SRC-002SRC-004SRC-005 |
| EC-006 | Augury operates in a competitive market with well-funded incumbents and specialist competitors. | partially verified medium | SRC-001SRC-002 |
| EC-007 | Augury has public management/team signals. | partially verified medium | SRC-005SRC-006 |
| EC-008 | Augury has public R&D/product pipeline signals. | partially verified medium | SRC-002SRC-004 |
| EC-009 | Augury has public legal, regulatory or restructuring signals that require counsel review. | partially verified medium | SRC-004SRC-005 |
| EC-010 | Augury has publicly visible brand/product/IP assets, but ownership and encumbrances are not fully public. | partially verified medium | SRC-002SRC-003 |
| EC-011 | Augury's audited financials, ARR/revenue, gross margin, cash, debt and tax positions are not public. | not publicly verifiable high | SRC-001 |
| EC-012 | Augury's top-customer revenue concentration, churn, NRR and customer contracts are not public. | not publicly verifiable high | SRC-002SRC-005 |
| EC-013 | Augury's sales productivity, CAC, quota attainment and channel economics are not public. | not publicly verifiable high | SRC-002 |
| ID | Publisher | Title | Accessed |
|---|---|---|---|
| SRC-001 | CB Insights | The Complete List Of Unicorn Companies | 2026-06-06 |
| SRC-002 | Augury | Industrial AI and Machine Health leader | Augury | 2026-06-06 |
| SRC-003 | Augury | Augury Raises $180 Million to Become One of the First Industry 4.0 Unicorns | 2026-06-06 |
| SRC-004 | Augury | AI Predictive Maintenance | Augury | 2026-06-06 |
| SRC-005 | Augury | Our Customers - Augury | 2026-06-06 |
| SRC-006 | Augury | Leadership | Augury | 2026-06-06 |
This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.